Alpenglow Biosciences to receive up to $21M through ARPA-H as part of the Cancer Moonshot initiative

Portfolio company Alpenglow Bioscience, a company reshaping pathology with their 3D spatial biology platform, announced they were awarded up to up to $21M in contracts from Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health (NIH). The contract also included partners Liu Biophotonics Lab at University of Washington, the Mahmood AI Lab at Harvard & Mass General Brigham, and Vanderbilt University Medical Center to develop a breakthrough technology for surgical oncology. The five-year ARPA-H contract is part of the Cancer Moonshot initiative spearheaded by the Biden administration. Alpenglow, alongside elite academic medical centers, is set to transform the fight against cancer with its innovative AI-driven 3D Spatial Biology platform.